These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32753585)

  • 21. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
    Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
    Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antimicrobial peptide LL-37 against biofilm forming Staphylococcus aureus strains obtained from chronic wound infections.
    Demirci M; Yigin A; Demir C
    Microb Pathog; 2022 Jan; 162():105368. PubMed ID: 34942309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SecDF on the antimicrobial functions of cathelicidins against Staphylococcus aureus.
    Blodkamp S; Kadlec K; Gutsmann T; Quiblier C; Naim HY; Schwarz S; von Köckritz-Blickwede M
    Vet Microbiol; 2017 Feb; 200():52-58. PubMed ID: 27062479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus.
    Nishi H; Komatsuzawa H; Fujiwara T; McCallum N; Sugai M
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4800-7. PubMed ID: 15561859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus.
    Benjamin AB; Moule MG; Didwania MK; Hardy J; Saenkham-Huntsinger P; Sule P; Nielsen JE; Lin JS; Contag CH; Barron AE; Cirillo JD
    Microbiol Spectr; 2022 Jun; 10(3):e0053422. PubMed ID: 35467395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus.
    Noore J; Noore A; Li B
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1283-90. PubMed ID: 23274662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial efficacy of antimicrobial peptide-functionalized hydrogel particles combined with vancomycin and oxacillin antibiotics.
    Stepulane A; Rajasekharan AK; Andersson M
    Int J Pharm; 2024 Oct; 664():124630. PubMed ID: 39216651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.
    Smith K; Gemmell CG; Lang S
    Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1327-32. PubMed ID: 23624635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.
    van Sorge NM; Beasley FC; Gusarov I; Gonzalez DJ; von Köckritz-Blickwede M; Anik S; Borkowski AW; Dorrestein PC; Nudler E; Nizet V
    J Biol Chem; 2013 Mar; 288(9):6417-26. PubMed ID: 23322784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
    Werth BJ; Sakoulas G; Rose WE; Pogliano J; Tewhey R; Rybak MJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):66-73. PubMed ID: 23070161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
    Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
    Ji M; Lee M; Noh S; Kim MN
    Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.
    Miyoshi N; Isogai E; Hiramatsu K; Sasaki T
    J Antibiot (Tokyo); 2017 Feb; 70(2):142-146. PubMed ID: 27531221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant
    Park K-H; Kim D; Jung M; Kim DY; Lee Y-M; Lee MS; Hong K-W; Bae I-G; Hong SI; Cho O-H
    Microbiol Spectr; 2024 Jun; 12(6):e0341223. PubMed ID: 38651875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
    Sader HS; Flamm RK; Jones RN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
    Peleg AY; Monga D; Pillai S; Mylonakis E; Moellering RC; Eliopoulos GM
    J Infect Dis; 2009 Feb; 199(4):532-6. PubMed ID: 19125671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.